Search results
David Boaz, RIP
Reason.com· 14 minutes agoDavid Boaz, longtime executive vice president at the Cato Institute, died this week at age 70 in hospice after a battle with cancer. Boaz was born in Kentucky in 1953 to a ...
AbbVie's ovarian cancer therapy succeeds in mid-stage trial
Reuters· 1 day ago, opens new tab said on Thursday its therapy to treat patients with a type of ovarian cancer has met...
Cancer patients often do better with less intensive treatment, new research finds
Hartford Courant· 4 days agoScaling back treatment for three kinds of cancer can make life easier for patients without...
2 Dividend Stocks Billionaires Are Buying: Should You?
The Motley Fool via AOL· 48 minutes agoMerck currently has one of the best-selling therapies in the world in its portfolio. That is none other than Keytruda, which has earned a slew of indications in treating various types of < ...
Short bouts of exercise may boost efficacy of some types of cancer treatment
MedicalNewsToday via AOL· 24 hours agoRecent research suggests that short bouts of moderate to intense exercise could boost the efficacy...
Life-Altering Treatment: Existing Cancer Drug Alleviates Rare Genetic Syndrome
SciTechDaily· 4 hours agoResearchers at the NIH have discovered new pathways that could lead to treatments for autoimmune...
Malignant breast cancer on an ultrasound: Signs and next steps
Medical News Today· 13 hours agoAn ultrasound can help doctors diagnose malignant breast cancer. However, other diagnostic...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 5 days agoThe approach isn’t entirely new: The first antibody drug conjugate was approved by the Food and Drug...
Prince William Shares Update on Kate Middleton Amid Cancer Treatment
E! News via Yahoo News· 2 days agoPrince William provided insight into how Kate Middleton has been doing as she continues her cancer...
Why Is Mid-Cap Cancer-Focused Replimune Stock Trading Higher On Thursday?
Benzinga via Yahoo Finance· 22 hours agoBristol-Myers Squibb Co’s (NYSE:BMY) Nivolumab, sold under the brand name Opdivo, is an anti-cancer...
